Revealing G4 Structures as Drug Targets: Exploring the Potential of Novel Therapeutic Agents

Read full text
Authors: Ying Che, Yi Peng, Xiaolong Pan, Xiaoyun Hu, Yating Zhao, Y Zhao, Caizhi Tian, Ming Yuan, Yuhang Yin, Rongquan Gan, Li Y, Zhanlei Pei
+7 more Shiyin Liu, Shiyin Liu, Haobo Dong, Yue Tan, Guogui Sun, Huizhe Wu, Minjie Wei
Cited by: 1
References: 161

Abstract

G-quadruplex (G4) structures represent noncanonical secondary formations found in DNA and RNA. Recent research reveals that G4s are abnormally enriched in various cancers, with closely linked to malignancy, metastatic potential, and prognosis. These structures have emerged as promising biomarkers for cancer with notable clinical relevance. Concurrently, investigations into compounds that selectively recognize DNA or RNA G4s as potential anticancer agents offer new avenues for early cancer diagnosis and therapeutic strategies. This review systematically analyzes the chemical structural characteristics, structure-activity relationships, anticancer effects, and mechanisms of G4-targeting molecules in cancer treatment. Additionally, it summarizes novel nucleic acid-based drugs targeting G4 structures, providing valuable insights for the future development of more specific and effective G4-targeted therapeutic agents.

Fields of Study & Subjects

Computational Drug Discovery Methods Click Chemistry and Applications Peptidase Inhibition and Analysis

Publication details

Journal / source
Research
Publisher
American Association for the Advancement of Science (AAAS)
Volume
9
Pages
1363–1363
Publication date
1 January 2026
Language
EN